Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : winpa -- Ignore unavailable to you. Want to Upgrade?

To: Winston Kim who wrote (4306)	1/13/1998 12:35:00 PM
From: Steve Smith	Read Replies (1) \| Respond to of 6855

Winston, GERN...my old buddy..I guess it was my most profitable trade of 1997. I think its rise is due to options activity. I would avoid shorting it...it has a low float. And it moves on any news release. steve

To: Winston Kim who wrote (4306)	1/13/1998 12:38:00 PM
From: pat w.	Read Replies (1) \| Respond to of 6855

win, i am watching AKLM also not long yet! GERN news ? SPLN with CBS football, do u see further incline. look that music ntki today here is news on GERN Aging in Human Cells Can Be Put on Hold; Study to Be Published in SCIENCE, January 16, 1998 PR Newswire - January 12, 1998 17:39 %HEA %MTC %PDT V%PRN P%PRN -------------------------------------------------------------------------------- Jump to first matched term The following information is embargoed until 4:00 p.m. on Thursday, Jan. 15. The embargoed study can be obtained on Jan. 12 by calling Science and News Information at 202-326-6440. The Alliance for Aging Research will sponsor a press conference on Thursday, January 15th at 4:00 p.m. at the National Press Club in Washington, DC, to announce a major new study which demonstrates successful intervention in the aging process in human cells. Researchers at Geron Corporation in Menlo Park, California and the University of Texas Southwestern Medical Center at Dallas report that they have introduced the enzyme telomerase into normal human cells, significantly increasing their lifespan. These findings confirm the role of telomerase as the key regulator of cell aging and may lead to new treatments for age-related diseases and conditions. The study will be published in SCIENCE on Friday, January 16, 1998. A panel of experts, including the study's authors, will discuss the key findings, assess their impact on research in human aging, as well as applications in treating aging-related diseases and conditions. PANELISTS Daniel Perry, Executive Director, Alliance for Aging Research Leonard Hayflick, PhD, Professor of Anatomy at the University of California, San Francisco, School of Medicine Woodring E. Wright, MD, PhD, Professor in the Department of Cell Biology and Neuroscience, University of Texas Southwestern Medical Center at Dallas Calvin B. Harley, PhD, Vice President and Chief Scientific Officer, Geron Corporation Malcolm A. S. Moore, D.Phil, Enid A. Haupt Professor of Cell Biology and Head, James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan Kettering Cancer Center WHEN: Thursday, January 15, 1998 at 4:00 p.m. EST WHERE: National Press Club - First Amendment Room 529 14th Street, NW, Washington, DC 202-662-7500 Persons receiving this information understand and agree that it is subject to a strict embargo until 4:00 p.m. EST, Thursday, Jan. 15, 1998. Its contents cannot be discussed with any other person or entity until such time, and, in no event should anyone purchase or sell securities of Geron Corporation or make any recommendation to others until after the embargo has been lifted. Failure to adhere strictly to the terms of this embargo will result in potential civil and criminal liability. CONTACT: Michele Riselli of the Alliance for Aging Research, 202-293-2856. SOURCE Alliance for Aging Research /PRNewswire -- Jan. 12/